Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Sandsmark

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Plos One|May 27, 2021
Exploring the diagnostic potential of adding T2 dependence in diffusion-weighted MR imaging of the prostateIngrid Framås Syversen, Mattijs Elschot, Elise Sandsmark, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
The Reproducibility of Deep Learning-Based Segmentation of the Prostate Gland and Zones on T2-Weighted MR ImagesMohammed R S Sunoqrot, Kirsten M Selnæs, Elise Sandsmark, et al.
Magnetic Resonance in Medicine|September 2, 2017
Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysisGabriel Nketiah, Kirsten M Selnaes, Elise Sandsmark, et al.
Frontiers in Oncology|December 1, 2018
Simultaneous <sup>18</sup>F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate CancerMorteza Esmaeili, Nassim Tayari, Tom Scheenen, et al.
Scientific Reports|October 29, 2017
SFRP4 gene expression is increased in aggressive prostate cancerElise Sandsmark, Maria K Andersen, Anna M Bofin, et al.
Diagnostics (Basel, Switzerland)|September 23, 2020
A Quality Control System for Automated Prostate Segmentation on T2-Weighted MRIMohammed R S Sunoqrot, Kirsten M Selnæs, Elise Sandsmark, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2016
A PET/MRI study towards finding the optimal [<sup>18</sup>F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancerMattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, et al.
Magma (New York, N.Y.)|August 9, 2023
The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics featuresDyah Ekashanti Octorina Dewi, Mohammed R S Sunoqrot, Gabriel Addio Nketiah, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2017
Combined <sup>18</sup>F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate CancerMattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, et al.
Magma (New York, N.Y.)|February 12, 2022
Pseudo-T2 mapping for normalization of T2-weighted prostate MRIKaia Ingerdatter Sørland, Mohammed R S Sunoqrot, Elise Sandsmark, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plos One|May 27, 2021
Exploring the diagnostic potential of adding T2 dependence in diffusion-weighted MR imaging of the prostateIngrid Framås Syversen, Mattijs Elschot, Elise Sandsmark, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
The Reproducibility of Deep Learning-Based Segmentation of the Prostate Gland and Zones on T2-Weighted MR ImagesMohammed R S Sunoqrot, Kirsten M Selnæs, Elise Sandsmark, et al.
Magnetic Resonance in Medicine|September 2, 2017
Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysisGabriel Nketiah, Kirsten M Selnaes, Elise Sandsmark, et al.
Frontiers in Oncology|December 1, 2018
Simultaneous <sup>18</sup>F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate CancerMorteza Esmaeili, Nassim Tayari, Tom Scheenen, et al.
Scientific Reports|October 29, 2017
SFRP4 gene expression is increased in aggressive prostate cancerElise Sandsmark, Maria K Andersen, Anna M Bofin, et al.
Diagnostics (Basel, Switzerland)|September 23, 2020
A Quality Control System for Automated Prostate Segmentation on T2-Weighted MRIMohammed R S Sunoqrot, Kirsten M Selnæs, Elise Sandsmark, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2016
A PET/MRI study towards finding the optimal [<sup>18</sup>F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancerMattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, et al.
Magma (New York, N.Y.)|August 9, 2023
The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics featuresDyah Ekashanti Octorina Dewi, Mohammed R S Sunoqrot, Gabriel Addio Nketiah, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2017
Combined <sup>18</sup>F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate CancerMattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, et al.
Magma (New York, N.Y.)|February 12, 2022
Pseudo-T2 mapping for normalization of T2-weighted prostate MRIKaia Ingerdatter Sørland, Mohammed R S Sunoqrot, Elise Sandsmark, et al.
Pageof 2